Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Jason Giffi, DO, DABOM board-certified in obesity medicine, a certified personal trainer, and an Ironman triathlete
The compound was originally developed by Eli Lilly and licensed to Innovent Biologics for development and commercialization in China
At Phase 3 (1.0 mg/week), you use 30 units per injection
Choi, B
Clinical Trial Results: Weight Loss & Key Outcomes Phase 2 (Published in NEJM & Nature Medicine) Obesity trial (NEJM 2023): Up to 24.2% mean weight loss at 48 weeks (12 mg dose)
US$ 22.94
US$ 23.56
US$ 28.45
